Search
for
Sort by
Research 30 of 1000+
- Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
- 0917 Finasteride is Associated with a Higher Odds of Obstructive Sleep Apnea (OSA): Results from the US FDA Adverse Events Reporting System (FAERS)
- 1173 The Role of Iron Metabolism in Obstructive Sleep Apnea Severity in Individuals with Androgenetic Alopecia (EPISONO)
- Dyslipidemia and obstructive sleep apnea in men with androgenetic alopecia: an analysis from the EPISONO study
- Obstructive Sleep Apnea and Sleep Quality in Women with Polycystic Ovary Syndrome: A Cross-sectional Study
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Obstructive Sleep Apnea Due to Endogenous Testosterone Production in a Woman
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Obstructive sleep apnea, low transferrin saturation levels, and male‐pattern baldness
- Associations Between Iron Metabolism and Obstructive Sleep Apnea Severity in Female and Male Individuals With Self‐Reported Androgenetic Alopecia: A Propensity‐Score Matching Analysis From the EPISONO Database
- PROGRESSIVE SLEEP APNOEAS RESPOND TO MEDROXYPROGESTERONE ACETATE
- 0914 Association Between Obstructive Sleep Apnea, Nightmare Disorder and Incident Herpes Zoster
- 1171 Obstructive Sleep Apnea and Its Effect on Non-Cystic Fibrosis Bronchiectasis Exacerbations: A National Inpatient Sample Study
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- 1172 The Development of Obstructive Sleep Apnea Following Radiotherapy and Chemotherapy: A Systematic Review and Meta-Analysis
- Reversible exacerbation of obstructive sleep apnea by α1-adrenergic blockade with tamsulosin: A case report
- 0557 Possible Contributory and Protective Factors in Medication Associated Obstructive Sleep Apnea (OSA): Results from the US Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS)
- Autosomal Dominant Obstructive Sleep Apnea Syndrome Due to the New Variant c.980_984dup in COL1A2: A Case Report
- Exploring the Causal Relationship Between Plasma Proteins and Obstructive Sleep Apnea: A Study Using Genome-Wide Mendelian Randomization, Single-Cell RNA Sequencing Analysis, and Network Pharmacology
- Neuroimaging of sleep and depression
- Testosterone Conversion Blockade Increases Breathing Stability in Healthy Men during NREM Sleep
- Beyond Counting Sheep: Exploring the Link between Polycystic Ovary Syndrome and Sleep Health
- Dyslipidemia, hormonal profiles, and sleep characteristics in men with androgenetic alopecia: an analysis based on data from the EPISONO study
- Potential adverse effects of long-term testosterone therapy
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Six-Month Quality of Life and Health Outcomes After Bariatric Surgery: A Prospective Cohort Study from Latvia
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment